Langley-Evans, SC. Nutrition in early life and the programming of adult disease: a review. J Hum Nutr Diet. 2015; 28, Suppl 1, 1–14.
Le Clair, C, Abbi, T, Sandhu, H, Tappia, PS. Impact of maternal undernutrition on diabetes and cardiovascular disease risk in adult offspring. Can J Physiol Pharmacol. 2009; 87(3), 161–179.
Langley-Evans, SC. Fetal programming of CVD and renal disease: animal models and mechanistic considerations. Proc Nutr Soc. 2013; 72(3), 317–325.
Godfrey, KM, Reynolds, RM, Prescott, SL, et al. Influence of maternal obesity on the long-term health of offspring. Lancet Diabetes Endocrinol. 2017; 5(1), 53–64.
Ribaroff, GA, Wastnedge, E, Drake, AJ, Sharpe, RM, Chambers, TJG. Animal models of maternal high fat diet exposure and effects on metabolism in offspring: a meta-regression analysis. Obes Rev. 2017; 18(6), 673–686.
Ainge, H, Thompson, C, Ozanne, SE, Rooney, KB. A systematic review on animal models of maternal high fat feeding and offspring glycaemic control. Int J Obes (Lond). 2011; 35(3), 325–335.
Muhlhausler, BS, Ailhaud, GP. Omega-6 polyunsaturated fatty acids and the early origins of obesity. Curr Opin Endocrinol Diabetes Obes. 2013; 20(1), 56–61.
Ramsden, CE, Faurot, KR, Zamora, D, et al. Targeted alteration of dietary n-3 and n-6 fatty acids for the treatment of chronic headaches: a randomized trial. Pain. 2013; 154(11), 2441–2451.
Blasbalg, TL, Hibbeln, JR, Ramsden, CE, Majchrzak, SF, Rawlings, RR. Changes in consumption of omega-3 and omega-6 fatty acids in the United States during the 20th century. Am J Clin Nutr. 2011; 93(5), 950–962.
Sioen, I, van Lieshout, L, Eilander, A, et al. Systematic review on N-3 and N-6 polyunsaturated fatty acid intake in European countries in light of the current recommendations – focus on specific population groups. Ann Nutr Metab. 2017; 70(1), 39–50.
Tarrade, A, Panchenko, P, Junien, C, Gabory, A. Placental contribution to nutritional programming of health and diseases: epigenetics and sexual dimorphism. J Exp Biol. 2015; 218(Pt 1), 50–58.
Singh, P, Saxena, R, Srinivas, G, Pande, G, Chattopadhyay, A. Cholesterol biosynthesis and homeostasis in regulation of the cell cycle. PLoS One, 2013; 8(3), e58833.
Fernández, C, Martín, M, Gómez-Coronado, D, Lasunción, MA. Effects of distal cholesterol biosynthesis inhibitors on cell proliferation and cell cycle progression. J Lipid Res. 2005; 46(5), 920–929.
Porter, FD. Malformation syndromes due to inborn errors of cholesterol synthesis. J Clin Invest. 2002; 110(6), 715–724.
Maymunah, AO, Kehinde, O, Abidoye, G, Oluwatosin, A. Hypercholesterolaemia in pregnancy as a predictor of adverse pregnancy outcome. Afr Health Sci. 2014; 14(4), 967–973.
Edison, RJ, Berg, K, Remaley, A, et al. Adverse birth outcome among mothers with low serum cholesterol. Pediatrics. 2007; 120(4), 723–733.
Baardman, ME, Kerstjens-Frederikse, WS, Berger, RM, et al. The role of maternal-fetal cholesterol transport in early fetal life: current insights. Biol Reprod. 2013; 88(1), 24.
Woollett, LA. Review: transport of maternal cholesterol to the fetal circulation. Placenta. 2011; 32, Suppl 2, S218–S221.
Stefulj, J, Panzenboeck, U, Becker, T, et al. Human endothelial cells of the placental barrier efficiently deliver cholesterol to the fetal circulation via ABCA1 and ABCG1. Circ Res. 2009; 104(5), 600–608.
Madsen, EM, Lindegaard, ML, Andersen, CB, Damm, P, Nielsen, LB, Human placenta secretes apolipoprotein B-100-containing lipoproteins. J Biol Chem. 2004; 279(53), 55271–55276.
Daniel, Z, Swali, A, Emes, R, Langley-Evans, SC. The effect of maternal undernutrition on the rat placental transcriptome: protein restriction up-regulates cholesterol transport. Genes Nutr. 2016; 11(1), 27.
Langley, SC, Jackson, AA. Increased systolic blood pressure in adult rats induced by fetal exposure to maternal low protein diets. Clin Sci (Lond). 1994; 86(2), 217–222; discussion 121.
Erhuma, A, Salter, AM, Sculley, DV, Langley-Evans, SC, Bennett, AJ. Prenatal exposure to a low-protein diet programs disordered regulation of lipid metabolism in the aging rat. Am J Physiol Endocrinol Metab. 2007; 292(6), E1702–E1714.
Swali, A, McMullen, S, Hayes, H, et al. Cell Cycle regulation and cytoskeletal remodelling are critical processes in the nutritional programming of embryonic development. PLoS One. 2011; 6(8), e23189.
McMullen, S, Langley-Evans, SC, Gambling, L, et al. A common cause for a common phenotype: the gatekeeper hypothesis in fetal programming. Med Hypotheses. 2012; 78(1), 88–94.
Draycott, SAV, Liu, G, Daniel, ZC, et al. Maternal dietary ratio of linoleic acid to alpha-linolenic acid during pregnancy has sex-specific effects on placental and fetal weights in the rat. Nutr Metab. 2019; 16(1), 1.
McClive, PJ, Sinclair, AH. Rapid DNA extraction and PCR-sexing of mouse embryos. Mol Reprod Dev. 2001; 60(2), 225–226.
Bhasin, KK, van Nas, A, Martin, LJ, et al. Maternal low-protein diet or hypercholesterolemia reduces circulating essential amino acids and leads to intrauterine growth restriction. Diabetes. 2009; 58(3), 559–566.
El-Sayyad, HI, Al-Haggar, MM, El-Ghawet, HA, Bakr, IH. Effect of maternal diabetes and hypercholesterolemia on fetal liver of albino Wistar rats. Nutrition. 2014; 30(3), 326–336.
Napoli, C, de Nigris, F, Welch, JS, et al. Maternal hypercholesterolemia during pregnancy promotes early atherogenesis in LDL receptor-deficient mice and alters aortic gene expression determined by microarray. Circulation. 2002; 105(11), 1360–1367.
Goharkhay, N, Sbrana, E, Gamble, PK, et al. Characterization of a murine model of fetal programming of atherosclerosis. Am J Obstet Gynecol. 2007; 197(4), 416.e1–416.e5.
Papacleovoulou, G, Abu-Hayyeh, S, Nikolopoulou, E, et al. Maternal cholestasis during pregnancy programs metabolic disease in offspring. J Clin Invest. 2013; 123(7), 3172–3181.
Napoli, C, D’Armiento, FP, Mancini, FP, et al. Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions. J Clin Invest. 1997; 100(11), 2680–2690.
Solini, A, Santini, E, Madec, S, Rossi, C, Muscelli, E, Retinol-binding protein-4 in women with untreated essential hypertension. Am J Hypertens. 2009; 22(9), 1001–1006.
Yang, Q, Graham, TE, Mody, N, et al. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature. 2005; 436(7049), 356–362.
Graham, TE, Yang, Q, Blüher, M, et al. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med, 2006; 354(24), 2552–2563.
Dubé, E, Gravel, A, Martin, C, et al. Modulation of fatty acid transport and metabolism by maternal obesity in the human full-term placenta. Biol Reprod. 2012; 87(1), 14, 1–11.
Barkley, MS, Geschwind, II, Bradford, GE, The gestational pattern of estradiol, testosterone and progesterone secretion in selected strains of mice. Biol Reprod. 1979; 20(4), 733–738.
Tal, R, Taylor, HS, Burney, RO, Mooney, SB, Giudice, LC. Endocrinology of pregnancy. In Endotext (eds. Feingold, KR et al.), 2000; MDText.com, Inc., South Dartmouth (MA).
Mullen, MP, Forde, N, Parr, MH, et al. Alterations in systemic concentrations of progesterone during the early luteal phase affect RBP4 expression in the bovine uterus. Reprod Fertil Dev. 2012; 24(5), 715–722.